SCHEMBL3661901

SCHEMBL3661901

CC1(OC(N)=O)CC=C(c2c[nH]c3cccnc23)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 3/20 0.37
KDR P35968 1/20 0.37
GSK3B P49841 1/20 0.37
PRKD3 O94806 1/20 0.36
PRKD1 Q15139 1/20 0.36
PRKD2 Q9BZL6 1/20 0.36
CYP2C19 P33261 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HTR1F P30939 2/20 0.33
CDK7 P50613 1/20 0.32
CDK9 P50750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23536571 0.75 FLT3 (0.39) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL3653965 0.73 HTR1D (0.41) FLT3KDRGSK3BCDK7CDK9
SCHEMBL23536526 0.72 FLT3 (0.34) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL3227382 0.72 FLT3 (0.36) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL13424862 0.70 CDK7 (0.34) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL3622286 0.70 FLT3 (0.35) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL23536767 0.70 KDR (0.34) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL3660344 0.70 CDK7 (0.36) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL3657163 0.69 JAK3 (0.36) FLT3KDRGSK3BPRKD3PRKD1
SCHEMBL16801705 0.68 PDE10A (0.49) FLT3KDRGSK3BPRKD2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010024980-A1 4'-AMINO CYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-03-04 WO disclosed